Adam Master

Adam Master

Auto-generated profile, based on publicly available information

Adam Master

Department of Biochemistry and Molecular Biology, The Medical Centre of Postgraduate Education, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2005 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PDF file
KSK. Switaj
K. Switaj
AMA. Master
A. Master
MSM. Skrzypczak
M. Skrzypczak
PZP. Zaborowski
P. Zaborowski

2 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJoanna Bogusławska
Joanna Bogusławska
AWAnna Wojcicka
Anna Wojcicka
APAgnieszka Piekielko-Witkowska
Agnieszka Piekielko-Witkowska
AMAdam Master
Adam Master
ANAlicja Nauman
Alicja Nauman
Type 1 iodothyronine deiodinase (DIO1) catalyses the conversion of prohormone thyroxine to the active thyroid hormone 3,3′,5-triiodothyronine (T3), important regulator of cell proliferation and differentiation. DIO1 expression is reduced in the most common type of kidney neoplasia, clear cell Renal Cell Carcinoma (ccRCC). MicroRNAs are small, non-coding RNAs that regulate gene expression at posttranscriptional levels. The aim of this study was to analyze the potential regulation of DIO1 expression by microRNAs in ccRCC. Bioinformatic analysis revealed that 3′UTR of the human DIO1 gene transcript contains miR-224 and miR-383 target sites, which are conserved across mammalian species. Semi-quantitative real-time PCR was used to analyze the expression of miR-224 and miR-383 in 32 samples of ccRCC tumors (T) and in 32 matched control (C) samples. We observed statistically significant (p = 0.0002) more than four fold increase in miR-224 expression and nearly two fold increase in miR-383 expression in samples T compared to samples C. Tumor specific changes in expression of miR-224 negatively correlated with changes in DIO1 expression and intracellular T3 concentration. Transfection of HeLa cell line with miR-224 and miR-383 suppressed the activity of a luciferase reporter containing the 3′UTR of DIO1. This was abolished when constructs mutated at the miR-224 and miR-383 target sites were used instead, indicating that miR-224 and miR-383 directly bind to DIO1 3′UTR. Finally, induced expression of miR-224 in Caki-2 cells resulted in significant (p<0.01) reduction of DIO1 mRNA. This study provides a novel miRNA-mediated regulatory mechanism of DIO1 expression in ccRCC.

1 November 2010 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
AMAdam Master
Adam Master
AWAnna Wójcicka
Anna Wójcicka
APAgnieszka Piekiełko-Witkowska
Agnieszka Piekiełko-Witkowska
JBJoanna Bogusławska
Joanna Bogusławska
PPPiotr Popławski
Piotr Popławski
ANAlicja Nauman
Alicja Nauman

1 November 2006 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
KSKarolina Switaj
Karolina Switaj
AMAdam Master
Adam Master
PBPiotr Karol Borkowski
Piotr Karol Borkowski
MSMagdalena Skrzypczak
Magdalena Skrzypczak
JWJacek Wojciechowicz
Jacek Wojciechowicz
PZPiotr Zaborowski
Piotr Zaborowski
Toxoplasma gondii strains were genotyped directly from blood samples of patients with ocular toxoplasmosis. Analysis of nontranscribed spacer 2 revealed that all detected strains belonged to type I, suggesting an association of ocular toxoplasmosis with this type. The method shows the usefulness of blood samples for genotyping in ocular toxoplasmosis.

21 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AWAnna Wójcicka
Anna Wójcicka
APAgnieszka Piekielko-Witkowska
Agnieszka Piekielko-Witkowska
HKHanna Kedzierska
Hanna Kedzierska
BRBeata Rybicka
Beata Rybicka
PPPiotr Poplawski
Piotr Poplawski
ANAlicja Nauman
Alicja Nauman
Thyroid hormone receptor beta (THRB) gene is commonly deregulated in cancers and, as strengthened by animal models, postulated to play a tumor-suppressive role. Our previous studies revealed downregulation of THRB in clear cell renal cell carcinoma (ccRCC), but the culpable mechanisms have not been fully elucidated. Since epigenetic regulation is a common mechanism influencing the expression of tumor suppressors, we hypothesized that downregulation of THRB in renal cancer results from epigenetic aberrances, including CpG methylation and microRNA-dependent silencing. Our study revealed that ccRCC tumors exhibited a 56% decrease in THRB and a 37% increase in DNA methyltransferase 1 (DNMT1) expression when compared with paired non-neoplastic control samples. However, THRB CpG methylation analysis performed using BSP, SNaPshot and MSP-PCR consistently revealed no changes in methylation patterns between matched tumor and control samples. In silico analysis resulted in identification of four microRNAs (miR-155, miR-425, miR-592, and miR-599) as potentially targeting THRB transcript. Luciferase assay showed direct binding of miR-155 and miR-425 to 3′UTR of THRB, and subsequent in vivo analyses revealed that transfection of UOK171 cell line with synthetic miR-155 or miR-425 resulted in decreased expression of endogenous TRHB by 22% and 64%, respectively. Finally, real-time PCR analysis showed significant upregulation of miR-155 (354%) and miR-425 (162%) in ccRCC when compared with matched controls. Moreover, microRNA levels were negatively correlated with the amount of THRB transcript in tissue samples. We conclude that CpG methylation is not the major mechanism contributing to decreased THRB expression in ccRCC. In contrast, THRB is targeted by microRNAs miR-155 and miR-425, whose increased expression may be responsible for downregulation of THRB in ccRCC tumors.

1 May 2014 in Atlas of Genetics and Cytogenetics in Oncology and Haematology
Verified
Journal Article
Open access
PDF file
AMA Master
A Master
ANA Nauman
A Nauman